Final rule reduces burdens to critical access hospitals, rural clinics; loosens physician supervision requirements.
Hospitals will save approximately $660 million a year thanks to a new government rule that removes unnecessary, obsolete or burdensome regulations, according to the Centers for Medicare & Medicaid Services (CMS).
The reforms, announced yesterday in a final rule, eliminates requirements that hinder hospitals or other healthcare organizations from providing high-quality patient care, the agency said in an announcement. CMS estimates organizations will save roughly $3.2 billion over the next five years as a result of the new rule. In addition, it projects that combined with President Barack Obama's "regulatory look-back" executive order, the two rules will save healthcare providers $8 million over the course of five years.
"By eliminating stumbling blocks and red tape we can assure that the healthcare that reaches patients is more timely, that it's the right treatment for the right patient, and greater efficiency improves patient care across the board," said CMS Administrator Marilyn Tavenner in the announcement.
Read the full story here: http://bit.ly/1qmiASE
Source: Fierce Healthcare
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More